Roflo, Crestila .
HRN: 21-92-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
CEFUROXIME 500MG (TAB)
09/13/2022
09/20/2022
PO
1tab
Q12H
TMSAF
Waiting Final Action
09/13/2022
METRONIDAZOLE 500MG (TAB)
09/13/2022
09/20/2022
PO
1tab
Q8H
TMSAF
Waiting Final Action